LEUVEN, Belgium, October 3, 2018 /PRNewswire/ -- Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class therapies for myelin-related diseases, announces the appointment of Ian J. Reynolds as its Chief Executive Officer (CEO). Ian is...
from PR Newswire: //https://ift.tt/2IyFvqb
No comments:
Post a Comment